Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trial.

Differences were nominally significant for the 6 U/kg group at weeks 4 to 8 (elbow) and weeks 6 to 12 (wrist), and for the 3 U/kg group at week 4 (elbow) and weeks 2, 8, and 12 (wrist) ( Supplementary Table 4 ).

also in 7,732 other papers